Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

431
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
431
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

333
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
333
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

569
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
569
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

405
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
405
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

486
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
486
Varicose Veins II: Diagnostic Studies and Interprofessional Care01:26

Varicose Veins II: Diagnostic Studies and Interprofessional Care

263
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
263

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Introducing the 2026 Focused Issue on Venous Disease: What excites us most about the future of this field.

Vascular medicine (London, England)·2026
Same author

Optimizing pulmonary embolism response team functionality: Outcomes of mechanical thrombectomy by interventional radiology and vascular surgery.

Vascular medicine (London, England)·2026
Same author

The long-term clinical impact of iliofemoral deep vein thrombosis.

Journal of vascular surgery. Venous and lymphatic disorders·2026
Same author

Endovascular Therapy for Post-Thrombotic Syndrome - A Randomized Trial.

The New England journal of medicine·2026
Same author

Advanced Therapy for Intermediate-Risk Pulmonary Embolism.

The New England journal of medicine·2026
Same author

Prevention of the Postthrombotic Syndrome: Where Do We Stand?

Seminars in interventional radiology·2025

Related Experiment Video

Updated: Mar 6, 2026

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
04:40

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models

Published on: January 5, 2024

3.3K

Deep Vein Thrombosis Interventions in Cancer Patients.

Resmi Ann Charalel1, Suresh Vedantham1

  • 1Interventional Radiology Section, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri.

Seminars in Interventional Radiology
|March 8, 2017
PubMed
Summary

Cancer patients face higher risks of deep vein thrombosis (DVT) and bleeding. Low-molecular-weight heparin is the primary treatment, with other interventions like filters and catheter-directed thrombolysis used judiciously for specific cases.

Keywords:
anticoagulationcancerdeep vein thrombosisstentthrombolysis

More Related Videos

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
06:45

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis

Published on: February 10, 2023

16.6K
A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

18.0K

Related Experiment Videos

Last Updated: Mar 6, 2026

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
04:40

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models

Published on: January 5, 2024

3.3K
Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
06:45

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis

Published on: February 10, 2023

16.6K
A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

18.0K

Area of Science:

  • Oncology
  • Vascular Medicine
  • Hematology

Background:

  • Cancer significantly elevates the risk of deep vein thrombosis (DVT), its recurrence, and treatment-related bleeding.
  • Managing DVT in cancer patients requires distinct clinical considerations due to these heightened risks.

Purpose of the Study:

  • To outline current therapeutic strategies for DVT in cancer patients.
  • To discuss the role of anticoagulation, inferior vena cava filters, and endovascular therapies in managing cancer-associated DVT.

Main Methods:

  • Review of current evidence and recommendations for DVT management in oncology.
  • Discussion of anticoagulation, inferior vena cava filters, catheter-directed thrombolysis (CDT), and endovascular stent placement.

Main Results:

  • Low-molecular-weight heparin is the preferred initial and long-term anticoagulation therapy.
  • Inferior vena cava filters are considered for specific cases with contraindications to anticoagulation or breakthrough pulmonary embolism (PE).
  • Catheter-directed thrombolysis (CDT) may prevent postthrombotic syndrome in selected patients with acute iliofemoral DVT and low bleeding risk.

Conclusions:

  • Current recommendations for endovascular therapies in cancer-related DVT are based on limited data.
  • Further research is needed to define the optimal use of endovascular interventions in this patient population.
  • Careful patient selection is crucial for interventions like CDT and endovascular stenting.